Leadership Expansion Supports Execution of Canton Network Infrastructure Strategy Former DRW and Citadel Leader Joins as COO to Drive Institutional Platform Expansion NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced that its Board of Directors (the "Board") has elected Mark Wendland, Chief Executive Officer, as Chairman of the Board and approved the appointment of Angela Radkowski as Chief Operating Officer, effective February 5, 2026. Mr. Wendland succeeds Vincent LoPriore, who will transition to a member of the Board after serving as Chairman since May 9, 2025.

Advances Digital Asset Treasury Strategy Through Contributions to Canton Network NEW YORK, Jan. 26, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced it has been approved to operate a Super Validator on the Canton Network, advancing its ability to secure transactions on the network while accruing rewards in the form of CC to bolster its digital asset treasury. Tharimmune will provide in-depth quarterly research highlighting onchain analytics, community development news, governance and "tokenomics" updates, as well as roadmap updates for the network.

Tharimmune, Inc. (THAR) is the first public Canton Coin (CC-USD) digital asset treasury, raising $545 million in November 2025. THAR's declared strategy includes acquiring Canton Coin, acting as a Super Validator to mint new Canton Coin, while investing in businesses that promote growth of the network. The Canton Network is backed by leading institutions like Goldman Sachs, Nasdaq, DTCC, and S&P Global, with robust early adoption and a unique burn-mint equilibrium model.

NEW YORK, Jan. 20, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR), the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced the pricing of a $55 million registered offering. Tharimmune, Inc. operates a differentiated digital asset treasury strategy by actively participating in the Canton Network – a privacy-enabled, secure blockchain hosting trillions in assets on chain.

NEW YORK--(BUSINESS WIRE)--Tharimmune, Inc. (NASDAQ: THAR) (“Tharimmune” or the “Company”), the first publicly traded company to leverage Canton Coin (“CC”) to support the Canton Network's ability to digitize traditional financial markets, today announced the appointment of seasoned financial executive Jacob Asbury as Chief Financial Officer, effective immediately. In this role, he will oversee all financial strategy and operations, including capital planning, treasury management, financial rep.

Tharimmune, Inc. (NASDAQ: THAR - Get Free Report) shares shot up 8.9% on Friday. The stock traded as high as $2.48 and last traded at $2.45. 254,850 shares traded hands during trading, a decline of 93% from the average session volume of 3,476,183 shares. The stock had previously closed at $2.25. Analyst Upgrades and Downgrades

RED BANK, NJ / ACCESS Newswire / July 23, 2025 / Tharimmune, Inc. (the "Company" and "Tharimmune") (Nasdaq Capital Market:THAR), a clinical-stage biotechnology company committed to pioneering therapies in immunology and inflammation, today announced the pricing of a registered direct public offering (the "RD Offering") with certain purchasers, under the Shelf Registration Statement (as defined below), of up to $1.74 million of the Company's securities (the "Securities") consisting of (i) 414,331 shares of Common Stock, par value $0.0001 per share (the "Common Stock") and 559,910 pre-funded warrants to acquire shares of Common Stock (the "RD Pre-Funded Warrants"), and (ii) 974,241 warrants to acquire shares of Common Stock at the exercise price of $1.66 per share (the "RD Common Warrant"), at the price of $1.786 per unit comprised of one share of Common Stock or RD Pre-Funded Warrant and RD Common Warrant purchased, which shall be effected pursuant to the terms of that certain Securities Purchase Agreement (the "RD SPA). Strategic Investors and Placement Details Gross proceeds from the offering are expected to be approximately $1.74 million before deducting placement agent fees and estimated offering expenses.